ACN vs NDRA · P/E 24, rev $17.60B vs P/E 0.0, $2.6M cap
Accenture plc (ACN) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
NDRA does not have a complete income-statement cache yet.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the ACN and NDRA stock pages for the full models.
Not investment advice.